News

Engicare presents its activities for the development of Biomolecules During a press conference held at the regional anticancer center Centre régional de lutte contre le cancer Georges François Leclerc at Dijon, the main actors of Engicare plateform platform met on Friday, June 28th to present their activities: <http://www.vootv.fr/video.php?key=gT4nbTyahk> This meeting was the opportunity to present Engicare’s platform and reminded the stakes issues for the development of biomolecules. Dr. David Vandroux, CEO of NVH Medicinal and Professor Pierre Fumoleau, General Manager of CGFL, highlighted the importance of using translational research tools (including imaging) in drug development. These tools are available through Engicare services and allow to accelerate the development of biomolecules.

Engicare® presents its activities for the development of Biomolecules

 During a press conference held at the regional anticancer center Centre régional de lutte contre le cancer Georges François Leclerc at Dijon, the main actors [...]

> Read more

Engicare® events

Engicare®  delegates will be present:

  • at the next imaging B4B-connexion event: 23rd and 24th October, 2013
  • at the next BIO-Europe in Vienna: 4th November to 6th [...]
    > Read more

Ce site utilise Google Analytics. En continuant à naviguer, vous nous autorisez à déposer des cookies à des fins de mesure d'audience. Pour s'opposer à ce dépôt vous pouvez cliquer ici.    X